ETrade Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	$215K	Buy	2,238 +501	+29%	+$48.1K	﹤0.01%	803
2020 Q2	$212K	Buy	+1,737	New	+$212K	﹤0.01%	762
2018 Q4	–	Sell	-4,535	Closed	-$558K	–	787
2018 Q3	$558K	Buy	+4,535	New	+$558K	0.02%	517